<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">Plerixafor dosing was timed to allow a 10–11-h interval between dosing on Day 4 and the initiation of apheresis on Day 5. Following a dose of G-CSF 10 μg/kg SC 1 h (±15 min) prior, standard apheresis was performed using three blood volumes (±10%). The same regimen was administered (i.e., plerixafor administration in the evening and G-CSF 1 h prior to apheresis the following morning) for a maximum of four aphereses or until ≥5 × 10
 <sup>6</sup> CD34
 <sup>+</sup> cells/kg had been collected. The decision to continue treatment and apheresis was based on the cumulative cell yield/kg after each apheresis session.
</p>
